825 results on '"Burris, Thomas P."'
Search Results
2. How to Make Glucocorticoids Safer
3. A Synthetic ERR Agonist Alleviates Metabolic Syndrome
4. Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney
5. International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023
6. Development and pharmacological evaluation of a new chemical series of potent pan-ERR agonists, identification of SLU-PP-915
7. Cholesterol and Other Steroids
8. The role of REV-ERB in NASH
9. Synthesis and structure activity relationship of the first class of LXR inverse agonists
10. Adropin: An endocrine link between the biological clock and cholesterol homeostasis
11. Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB
12. The Orphan Nuclear Receptor TLX Is a Receptor for Synthetic and Natural Retinoids
13. Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
14. Modulation of estrogen-related receptors subtype selectivity: Conversion of an ERRβ/γ selective agonist to ERRα/β/γ pan agonists
15. Extending apo-sGC to haem-sensing proteins and a landscape of haem mimetic pharmacophores with broad applications
16. The nuclear receptor REV-ERBα modulates Th17 cell-mediated autoimmune disease
17. Structural Insights into Estrogen Receptors and Antiestrogen Therapies
18. Restoration of the molecular clock is tumor suppressive in neuroblastoma
19. Circadian clock protein Rev-erbα regulates neuroinflammation
20. International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands.
21. Merging Natural Product Structures with Pharmaceutical Leads: Unnatural Enantiomers of Estranes as Glucocorticoid Receptor Modulators That Suppress TNF‑α and IL‑6 Release.
22. RORγ regulates the NLRP3 inflammasome
23. Retinoic Acid Receptors (RARA, RARB, and RARC)
24. Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice
25. REV-ERBβ is required to maintain normal wakefulness and the wake-inducing effect of dual REV-ERB agonist SR9009
26. Helix-Stabilized Cyclic Peptides as Selective Inhibitors of Steroid Receptor-Coactivator Interactions
27. Rev-Erb co-regulates muscle regeneration via tethered interaction with the NF-Y cistrome
28. Rev-erb regulation of cholesterologenesis
29. Disrupting the key circadian regulator CLOCK leads to age-dependent cardiovascular disease
30. Clock regulation of protein secretion
31. The Circadian Clock as a Drug Target
32. Inhibition of RORα/γ suppresses atherosclerosis via inhibition of both cholesterol absorption and inflammation
33. Structural Insights into Estrogen Receptors and Antiestrogen Therapies
34. SR9009 administered for one day after myocardial ischemia-reperfusion prevents heart failure in mice by targeting the cardiac inflammasome
35. A synthesis strategy for tetracyclic terpenoids leads to agonists of ERβ
36. From Functional Fatty Acids to Potent and Selective Natural-Product-Inspired Mimetics via Conformational Profiling.
37. Rev-erbα agonists suppresses TGFβ1-induced fibroblast-to-myofibroblast transition and pro-fibrotic phenotype in human lung fibroblasts
38. REV-ERB activation as a novel pharmacological approach for treating inflammatory pain
39. Data from Fructose Promotes Cytoprotection in Melanoma Tumors and Resistance to Immunotherapy
40. Supplemental Figures S1-S9 from Fructose Promotes Cytoprotection in Melanoma Tumors and Resistance to Immunotherapy
41. Anti-proliferative actions of a synthetic REV-ERBα/β agonist in breast cancer cells
42. Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis
43. The Optimal Corepressor Function of Nuclear Receptor Corepressor (NCoR) for Peroxisome Proliferator-activated Receptor γ Requires G Protein Pathway Suppressor 2
44. The Estrogen Receptor-Related Orphan Receptors (ERRs) Regulate Autophagy through TFEB
45. Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases
46. Clock genes, pancreatic function, and diabetes
47. Structure of REV-ERBβ Ligand-binding Domain Bound to a Porphyrin Antagonist
48. Artemisia extracts activate PPARγ, promote adipogenesis, and enhance insulin sensitivity in adipose tissue of obese mice
49. A Synthetic ERRα Agonist Induces an Acute Aerobic Exercise Response and Enhances Exercise Capacity
50. Nuclear Receptors and Their Selective Pharmacologic Modulators
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.